Loading

NORML Blog

  • by Paul Armentano, NORML Deputy Director December 11, 2017

    oil_bottlesThe use of the naturally occurring cannabinoid CBD is safe, well tolerated, and is not associated with any significant adverse public health effects, according to the findings of a preliminary report compiled by the World Health Organization’s Expert Committee on Drug Dependence.

    Authors of the report declare that CBD is “not associated with abuse potential” and that it does not induce physical dependence. “CBD is generally well tolerated with a good safety profile,” they conclude.

    Nonetheless, they acknowledge that CBD remains classified as a schedule I controlled substance under US federal law – a classification that defines it as possessing a “high potential for abuse.”

    The WHO report also comments on CBD’s therapeutic efficacy, finding that the substance has “been demonstrated as an effective treatment for epilepsy,” and that there exists “preliminary evidence that CBD may be a useful treatment for a number of other medical conditions,” including Alzheimer’s disease, cancer, Parkinson’s disease, and psychosis.

    While authors acknowledge that the “unsanctioned medical use of CBD” oils and extracts is relatively common, they affirm, “[T]here is no evidence of recreational use of CBD or any public health related problems associated with the use of pure CBD.”

    The World Health Organization is in the process of considering whether to place CBD within the agency’s international drug scheduling code. In September, NORML submitted written testimony to the US Food and Drug Administration in opposition to the enactment of new international restrictions regarding CBD access. The FDA is one of a number of agencies advising WHO in their final review.

    Full text of the preliminary report appears online here. The full text of NORML’s written testimony appears here.

  • by Justin Strekal, NORML Political Director December 8, 2017

    Medical marijuanaCongressional leadership voted to enact a two-week continuing resolution that maintains present federal spending levels and priorities through December 22, 2017. The resolution extends medical cannabis patient protections imposed by the Rohrabacher-Blumenauer amendment until that date.

    The amendment, which has been in place since 2014, maintains that federal funds cannot be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.”

    “While we are pleased that these critical protections will continue, two weeks is not enough certainty for the millions of Americans who rely on medical marijuana for treatment and the businesses who serve them. As Congress works out a long-term funding bill, it must also include these protections. And ultimately, Congress must act to put an end to the cycle of uncertainty and permanently protect state medical marijuana programs—and adult use—from federal interference. The American people have spoken. It’s past time that Congress catch up.” – Representative Earl Blumenauer (D-OR)

    Reps Rohrabacher and Blumenauer are both co-chairs of the bipartisan Congressional Cannabis Caucus.

    Congressional leadership must reauthorize this language as part of the forthcoming budget in order for the provisions to stay in effect. In July, Sen. Patrick Leahy (D-VT) offered identical language before the Senate Appropriations Committee, which approved it. However, House Rules Committee Chair Peter Sessions (R-TX) has refused to allow House members to vote on similar language. The provision will now be considered by House and Senate leadership when the two chambers’ appropriations bills are reconciled.

    Send a message to your federal lawmakers in support of continuing these protections beyond December 22nd by clicking here. 

  • by Paul Armentano, NORML Deputy Director December 1, 2017

    personal_cultivationSales of alcoholic beverages decline following the enactment of medical marijuana access laws, according to a working paper authored by a team of researchers from the University of Connecticut and Georgia State University.

    Authors evaluated the relationship between medical marijuana laws and retail alcohol sales for more than 2,000 US counties for the years 2006 to 2015. Alcohol sales trends in medical cannabis states were compared to sales trends in states where cannabis remained illegal. Researchers determined that counties located in medical cannabis states, on average, experienced a reduction in monthly alcohol sales of 15 percent.

    Researchers concluded: “We find that marijuana and alcohol are strong substitutes. … States legalizing medical marijuana use experience significant decreases in the aggregate sale of alcohol, beer and wine. Moreover, the effects are not short-lived, with significant reductions observed up to 24 months after the passage of the law.”

    Consumer trend data from California reports that those with legal access to cannabis frequently reduce their alcohol intake. A 2016 analysis of beer sales in Colorado, Oregon, and Washington reported that retail sales “collectively underperformed” in the years following the enactment of adult use marijuana regulation.

    Full text of the study, “Helping settle the marijuana and alcohol debate: Evidence from scanner data,” appears online here.

  • by Justin Strekal, NORML Political Director November 29, 2017

    Congressman Dana Rohrabacher (R-CA) addresses NORML members in September, 2017

    Today, sixty-six members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.

    This comes on the same day the Attorney General Jeff Sessions held a press conference to discuss America’s opioid epidemic and made disparaging comments about marijuana.

    “We’re working on that very hard right now,” Sessions said on Wednesday. “We had meetings yesterday and talked about it at some length. It’s my view that the use of marijuana is detrimental and we should not give encouragement in any way to it. And it represents a federal violation which is in the law and is subject to being enforced, and our priorities will have to be focused on all the things and challenges that we face.”

    From Rep. Rohrabacher’s press release:

    Representatives Dana Rohrabacher (CA-48) and Earl Blumenauer (OR-03) spearheaded a letter, signed by 64 other members of the House of Representatives, urging House and Senate leadership to ensure the inclusion of medical marijuana protections in any appropriations bill that funds the government beyond December 8, 2017. The provision, previously known as “Rohrabacher-Farr,” and now “Rohrabacher-Blumenauer,” bars the Department of Justice from using appropriated funds to prosecute individuals who are acting in compliance with their state’s medical marijuana laws. The provision was first signed into law in December 2014 as part of a larger spending package, and has been in force ever since.

    Congressman Earl Blumenauer (D-OR) speaking a NORML Conference

    Reps Rohrabacher and Blumenauer are both co-chairs of the bipartisan Congressional Cannabis Caucus.

    In September, President Donald Trump reached an agreement with Congressional leadership to enact a three-month continuing resolution that maintains present federal spending levels and priorities through December 8, 2017, which included the amendment that was passed in the previous session of Congress.

    Congressional leadership must reauthorize this language as part of the forthcoming budget in order for the provisions to stay in effect. In July, Sen. Patrick Leahy (D-VT) offered identical language before the Senate Appropriations Committee, which approved it. However, House Rules Committee Chair Peter Sessions (R-TX) has refused to allow House members to vote on similar language. The provision will now be considered by House and Senate leadership when the two chambers’ appropriations bills are reconciled.

    It is imperative that the Rohrabacher-Blumenauer amendment remain the law of the land and AG Sessions not be given the green-light to enact a crackdown. Click here to send a message to your federal lawmakers and urge them to speak out about the need to protect the 2 million registered medical marijuana patients throughout the country.

  • by Justin Strekal, NORML Political Director
    Rick Steves with Illinois NORML's Ali Nagib

    Rick Steves with Illinois NORML’s Ali Nagib

    On Tuesday, travel radio and television host Rick Steves, a NORML Board Member, journeyed to Illinois to testify in support of marijuana legalization effort in the state legislature.

    “When you legalize marijuana, use does not go up, teen use does not go up, crime does not go up, what goes up ix tax revenue, what goes down is the black market,” Steves said. “Seventy thousand people are locked up in our country every year, 700,000 people are arrested, for possession of marijuana, not violent crimes. They’re not rich white guys, they’re poor people and they’re black people. It’s amazing that it’s happening in our country right now and there is just a way out of this.”

    Steves is well known for his public support of reform and has dedicated a tremendous amount of time and energy in support of outright legalization. During his press conference in Chicago, he was flanked by state lawmakers who have introduced the legislation. In their remarks, they laid out the economic realities of prohibition.

    “It is clear that prohibition doesn’t work and that by lifting cannabis restrictions we can encourage economic development in Illinois,” State Senator Heather Steans (D-Chicago) said. “We are carefully considering all aspects and potential impacts of legalizing adult-use cannabis, including job growth.”

    “Legalizing cannabis will spur the creation of new small businesses and much-needed jobs,” State Representative Kelly Cassidy (D-Chicago) said. “We are leaving hundreds of millions of dollars in economic activity on the table by continuing the outdated status quo of prohibition.”

    A recent poll of Illinois voters shows that 66% support the outright legalization of marijuana, and 74% support an end to arrests and penalties for simple possession.

    You can watch the press conference by clicking here.

    Make sure to follow Illinois NORML on Facebook, Twitter, and visit their website: https://illinoisnorml.org/

Page 1 of 48212345...102030...Last »